JOHN CARRINGTON: Open Payments
NPI 1821011529 · GERING, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$81 in 4 payments from 4 companies in 2025. Trend: 2023 $67 · 2024 $285 · 2025 $81
Food & beverage: $81
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: FREESTYLE LIBRE 3, Epclusa, PIFELTRO, WAINUA.
Industry payments across NE — which companies pay providers there.
